Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
P 2 (2)

Trial Status

Not Yet Recruiting1
Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07413900Recruiting

Biomarkers Study in Infants With Prior Neonatal Brain Injury

NCT06985290Phase 2Not Yet Recruiting

Dexmedetomidine Versus Morphine During Cooling Therapy in Neonates

NCT02499393Phase 2CompletedPrimary

Hypothermia Enhanced by Magnesium Sulphate

Showing all 3 trials

Research Network

Activity Timeline